Pharmaceutical company Pfizer led the round for the company, which has now raised $26m in total.

NeuMoDx Molecular, a US-based developer of a molecular testing platform, has closed a $21m series B round led by Pfizer Ventures, the corporate venturing subsidiary of drug company Pfizer.

Pfizer was joined in the round by venture capital firms Baird Capital and Arboretum Ventures, and Wolverine Venture Fund, a student-led VC fund based at the University of Michigan. Arboretum was previously the sole investor in NeuMoDx’s $5m series A round in 2012.

NeuMoDx will use the funding to support its…